نتائج البحث - Padget, Michelle
- يعرض 1 - 19 نتائج من 19
-
1
-
2
Direct and antibody-dependent cell-mediated cytotoxicity of head and neck squamous cell carcinoma cells by high-affinity natural killer cells حسب Friedman, Jay, Padget, Michelle, Lee, John, Schlom, Jeffrey, Hodge, James, Allen, Clint
منشور في 2019نص -
3
Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve حسب Fabian, Kellsye P, Padget, Michelle R, Fujii, Rika, Schlom, Jeffrey, Hodge, James W
منشور في 2021نص -
4
Cisplatin and Oxaliplatin Induce Similar Immunogenic Changes in Preclinical Models of Head and Neck Cancer حسب Park, So-Jin, Ye, Wenda, Xiao, Roy, Silvin, Christopher, Padget, Michelle, Hodge, James W., Waes, Carter Van, Schmitt, Nicole C.
منشور في 2019نص -
5
Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies حسب Friedman, Jay, Morisada, Megan, Sun, Lillian, Moore, Ellen C., Padget, Michelle, Hodge, James W., Schlom, Jeffrey, Gameiro, Sofia R., Allen, Clint T.
منشور في 2018نص -
6
Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune-Tumor Interactions: Engage, Expand, Enable حسب Fabian, Kellsye P., Malamas, Anthony S., Padget, Michelle R., Solocinski, Kristen, Wolfson, Benjamin, Fujii, Rika, Sater, Houssein Abdul, Schlom, Jeffrey, Hodge, James W.
منشور في 2020نص -
7
Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition... حسب Fenerty, Kathleen E., Padget, Michelle, Wolfson, Benjamin, Gameiro, Sofia R., Su, Zhen, Lee, John H., Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Hodge, James W.
منشور في 2018نص -
8
Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PA... حسب Fenerty, Kathleen E., Padget, Michelle, Wolfson, Benjamin, Gameiro, Sofia R., Su, Zhen, Lee, John H., Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Hodge, James W.
منشور في 2019نص -
9
Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells حسب Hoke, Austin T.K., Padget, Michelle R., Fabian, Kellsye P., Nandal, Anjali, Gallia, Gary L., Bilusic, Marijo, Soon-Shiong, Patrick, Hodge, James W., London, Nyall R.
منشور في 2021نص -
10
Overcoming hypoxia-induced functional suppression of NK cells حسب Solocinski, Kristen, Padget, Michelle R, Fabian, Kellsye P, Wolfson, Benjamin, Cecchi, Fabiola, Hembrough, Todd, Benz, Stephen C, Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Schlom, Jeffrey, Hodge, James W
منشور في 2020نص -
11
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations حسب Fabian, Kellsye P, Padget, Michelle R, Donahue, Renee N., Solocinski, Kristen, Robbins, Yvette, Allen, Clint T., Lee, John H., Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Schlom, Jeffrey, Hodge, James W
منشور في 2020نص -
12
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells حسب Lee, Maxwell Y, Robbins, Yvette, Sievers, Cem, Friedman, Jay, Abdul Sater, Houssein, Clavijo, Paul E, Judd, Nancy, Tsong, Edward, Silvin, Chris, Soon-Shiong, Patrick, Padget, Michelle R, Schlom, Jeffrey, Hodge, James, Hinrichs, Christian, Allen, Clint
منشور في 2021نص -
13
Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia حسب Sasaki, Takayo, Rivera-Mulia, Juan Carlos, Vera, Daniel, Zimmerman, Jared, Das, Sunny, Padget, Michelle, Nakamichi, Naoto, Chang, Bill H., Tyner, Jeff, Druker, Brian J., Weng, Andrew P., Civin, Curt I., Eaves, Connie J., Gilbert, David M.
منشور في 2017نص -
14
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells حسب Robbins, Yvette, Greene, Sarah, Friedman, Jay, Clavijo, Paul E, Van Waes, Carter, Fabian, Kellsye P, Padget, Michelle R, Abdul Sater, Houssein, Lee, John H, Soon-Shiong, Patrick, Gulley, James, Schlom, Jeffrey, Hodge, James W, Allen, Clint T
منشور في 2020نص -
15
An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele حسب Jochems, Caroline, Hodge, James W., Fantini, Massimo, Fujii, Rika, Maurice, Y. Morillon, Greiner, John W., Padget, Michelle R., Tritsch, Sarah R., Tsang, Kwong Yok, Campbell, Kerry S., Klingemann, Hans, Boissel, Laurent, Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Schlom, Jeffrey
منشور في 2016نص -
16
EXTH-63. EFFICIENT ADCC-MEDIATED KILLING OF MALIGNANT MENINGIOMA CELLS USING AVELUMAB AND AN ENGINEERED HIGH AVIDITY NATURAL KILLER CELL LINE, haNK حسب Giles, Amber, Hao, Shuyu, Fuji, Rika, Padget, Michelle, Song, Hua, Zhang, Wei, Cao, Xiaoyu, Jung, Jinkyu, Liu, Yang, Jensen, Randy, Lee, John, Shiong, Patrick Soon, Gillespie, David, Schlom, Jeffrey, Gilbert, Mark, Yang, Chunzhang, Hodge, James, Park, Deric
منشور في 2018نص -
17
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile حسب Cramer-Morales, Kimberly, Nieborowska-Skorska, Margaret, Scheibner, Kara, Padget, Michelle, Irvine, David A., Sliwinski, Tomasz, Haas, Kimberly, Lee, Jaewoong, Geng, Huimin, Roy, Darshan, Slupianek, Artur, Rassool, Feyruz V., Wasik, Mariusz A., Childers, Wayne, Copland, Mhairi, Müschen, Markus, Civin, Curt I., Skorski, Tomasz
منشور في 2013نص -
18
Combination of PARP inhibitor olaparib, and PD-L1 inhibitor durvalumab, in recurrent ovarian cancer: a proof-of-concept phase 2 study حسب Lampert, Erika J., Zimmer, Alexandra, Padget, Michelle, Cimino-Mathews, Ashley, Nair, Jayakumar, Liu, Yingmiao, Swisher, Elizabeth M., Hodge, James W., Nixon, Andrew B., Nichols, Erin, Bagheri, Mohammad H., Levy, Elliott, Radke, Marc R., Lipkowitz, Stanley, Annunziata, Christina M., Taube, Janis M., Steinberg, Seth M., Lee, Jung-Min
منشور في 2020نص -
19
Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK حسب Giles, Amber J., Hao, Shuyu, Padget, Michelle, Song, Hua, Zhang, Wei, Lynes, John, Sanchez, Victoria, Liu, Yang, Jung, Jinkyu, Cao, Xiaoyu, Fujii, Rika, Jensen, Randy, Gillespie, David, Schlom, Jeffrey, Gilbert, Mark R., Nduom, Edjah K., Yang, Chunzhang, Lee, John H., Soon-Shiong, Patrick, Hodge, James W., Park, Deric M.
منشور في 2019نص